{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:06:45Z","timestamp":1794960405989,"version":"4.9.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Long Interspersed Nuclear Element-1 (LINE-1, L1) is increasingly regarded as a genetic risk for lung cancer. Transcriptionally active LINE-1 forms a L1-gene chimeric transcript (LCTs), through somatic L1 retrotransposition (LRT) or L1 antisense promoter (L1-ASP) activation, to play an oncogenic role in cancer progression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Here, we developed Retrotransposon-gene fusion estimation program (ReFuse), to identify and quantify LCTs in RNA sequencing data from TCGA lung cancer cohort (<jats:italic>n<\/jats:italic>\u2009=\u20091146) and a single cell RNA sequencing dataset then further validated those LCTs in an independent cohort (<jats:italic>n<\/jats:italic>\u2009=\u2009134). We next examined the functional roles of a cancer specific LCT (<jats:italic>L1-FGGY<\/jats:italic>) in cell proliferation and tumor progression in LUSC cell lines and mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The LCT events correspond with specific metabolic processes and mitochondrial functions and was associated with genomic instability, hypomethylation, tumor stage and tumor immune microenvironment (TIME). Functional analysis of a tumor specific and frequent LCT involving <jats:italic>FGGY<\/jats:italic> (<jats:italic>L1-FGGY<\/jats:italic>) reveal that the arachidonic acid (AA) metabolic pathway was activated by the loss of <jats:italic>FGGY<\/jats:italic> through the <jats:italic>L1-FGGY<\/jats:italic> chimeric transcript to promote tumor growth, which was effectively targeted by a combined use of an anti-HIV drug (NVR) and a metabolic inhibitor (ML355). Lastly, we identified a set of transcriptomic signatures to stratify the LUSC patients with a higher risk for poor outcomes who may benefit from treatments using NVR alone or combined with an anti-metabolism drug.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study is the first to characterize the role of L1 in metabolic reprogramming of lung cancer and provide rationale for L1-specifc prognosis and potential for a therapeutic strategy for treating lung cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Study on the mechanisms of the mobile element <jats:italic>L1-FGGY<\/jats:italic> promoting the proliferation, invasion and immune escape of lung squamous cell carcinoma through the 12-LOX\/Wnt pathway, Ek2020111. Registered 27 March 2020 \u2010 Retrospectively registered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12943-022-01618-5","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T09:03:14Z","timestamp":1657962194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Zeguo","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengpeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Francoeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Yee","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengzi","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sebra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,16]]},"reference":[{"issue":"6822","key":"1618_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/35057062","volume":"409","author":"ES Lander","year":"2001","unstructured":"Lander ES, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860\u2013921.","journal-title":"Nature"},{"issue":"6","key":"1618_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1101\/gr.201814.115","volume":"26","author":"EC Scott","year":"2016","unstructured":"Scott EC, et al. A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer. Genome Res. 2016;26(6):745\u201355.","journal-title":"Genome Res"},{"issue":"5","key":"1618_CR3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1006\/geno.2002.6758","volume":"79","author":"P Nigumann","year":"2002","unstructured":"Nigumann P, et al. Many human genes are transcribed from the antisense promoter of L1 retrotransposon. Genomics. 2002;79(5):628\u201334.","journal-title":"Genomics"},{"issue":"6","key":"1618_CR4","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1128\/MCB.21.6.1973-1985.2001","volume":"21","author":"M Speek","year":"2001","unstructured":"Speek M. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol. 2001;21(6):1973\u201385.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"1618_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/gutjnl-2012-304219","volume":"63","author":"K Hur","year":"2014","unstructured":"Hur K, et al. Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis. Gut. 2014;63(4):635\u201346.","journal-title":"Gut"},{"issue":"4","key":"1618_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000917","volume":"6","author":"EM Wolff","year":"2010","unstructured":"Wolff EM, et al. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet. 2010;6(4): e1000917.","journal-title":"PLoS Genet"},{"key":"1618_CR7","doi-asserted-by":"crossref","unstructured":"Kim, S., et al., Differential expressions of L1-chimeric transcripts in normal and matched-cancer tissues. Analytical Biochemistry, 2020. 600.","DOI":"10.1016\/j.ab.2020.113769"},{"issue":"7","key":"1618_CR8","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.cell.2010.05.020","volume":"141","author":"RC Iskow","year":"2010","unstructured":"Iskow RC, et al. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell. 2010;141(7):1253\u201361.","journal-title":"Cell"},{"issue":"12","key":"1618_CR9","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1101\/gr.145235.112","volume":"22","author":"S Solyom","year":"2012","unstructured":"Solyom S, et al. Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res. 2012;22(12):2328\u201338.","journal-title":"Genome Res"},{"issue":"35","key":"1618_CR10","doi-asserted-by":"publisher","first-page":"E4894","DOI":"10.1073\/pnas.1502474112","volume":"112","author":"TT Doucet-O'Hare","year":"2015","unstructured":"Doucet-O\u2019Hare TT, et al. LINE-1 expression and retrotransposition in Barrett\u2019s esophagus and esophageal carcinoma. Proc Natl Acad Sci U S A. 2015;112(35):E4894\u2013900.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1618_CR11","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1101\/gr.196238.115","volume":"25","author":"AD Ewing","year":"2015","unstructured":"Ewing AD, et al. Widespread somatic L1 retrotransposition occurs early during gastrointestinal cancer evolution. Genome Res. 2015;25(10):1536\u201345.","journal-title":"Genome Res"},{"issue":"9","key":"1618_CR12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nm.3919","volume":"21","author":"N Rodic","year":"2015","unstructured":"Rodic N, et al. Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma. Nat Med. 2015;21(9):1060\u20134.","journal-title":"Nat Med"},{"issue":"5","key":"1618_CR13","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41588-019-0416-9","volume":"51","author":"HS Jang","year":"2019","unstructured":"Jang HS, et al. Transposable elements drive widespread expression of oncogenes in human cancers (vol 51, pg 611, 2019). Nat Genet. 2019;51(5):920\u2013920.","journal-title":"Nat Genet"},{"issue":"19","key":"1618_CR14","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1093\/bioinformatics\/btz130","volume":"35","author":"A Babaian","year":"2019","unstructured":"Babaian A, et al. LIONS: analysis suite for detecting and quantifying transposable element initiated transcription from RNA-seq. Bioinformatics. 2019;35(19):3839\u201341.","journal-title":"Bioinformatics"},{"issue":"4","key":"1618_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/bioinformatics\/btx671","volume":"34","author":"ME Pinson","year":"2018","unstructured":"Pinson ME, et al. CLIFinder: identification of LINE-1 chimeric transcripts in RNA-seq data. Bioinformatics. 2018;34(4):688\u201390.","journal-title":"Bioinformatics"},{"issue":"2","key":"1618_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1618_CR17","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","volume":"83","author":"JR Molina","year":"2008","unstructured":"Molina JR, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584\u201394.","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"1618_CR18","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1101\/gr.163659.113","volume":"24","author":"E Helman","year":"2014","unstructured":"Helman E, et al. Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing. Genome Res. 2014;24(7):1053\u201363.","journal-title":"Genome Res"},{"issue":"17","key":"1618_CR19","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1158\/0008-5472.CAN-19-0076","volume":"79","author":"R Zhang","year":"2019","unstructured":"Zhang R, et al. LINE-1 Retrotransposition Promotes the Development and Progression of Lung Squamous Cell Carcinoma by Disrupting the Tumor-Suppressor Gene FGGY. Cancer Res. 2019;79(17):4453\u201365.","journal-title":"Cancer Res"},{"key":"1618_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41525-019-0077-8","volume":"4","author":"S Fan","year":"2019","unstructured":"Fan S, et al. Integrative analysis with expanded DNA methylation data reveals common key regulators and pathways in cancers. NPJ Genom Med. 2019;4:2.","journal-title":"NPJ Genom Med"},{"issue":"9","key":"1618_CR21","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/cdd.2012.35","volume":"19","author":"EM Schweikert","year":"2012","unstructured":"Schweikert EM, et al. PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death. Cell Death Differ. 2012;19(9):1549\u201360.","journal-title":"Cell Death Differ"},{"issue":"5","key":"1618_CR22","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1111\/jcmm.13595","volume":"22","author":"Y Chen","year":"2018","unstructured":"Chen Y, et al. INPP4B restrains cell proliferation and metastasis via regulation of the PI3K\/AKT\/SGK pathway. J Cell Mol Med. 2018;22(5):2935\u201343.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"1618_CR23","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1096\/fj.201500076","volume":"30","author":"KV Honn","year":"2016","unstructured":"Honn KV, et al. 12-HETER1\/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression. FASEB J. 2016;30(6):2360\u20139.","journal-title":"FASEB J"},{"issue":"7","key":"1618_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc.2017.35","volume":"17","author":"KH Burns","year":"2017","unstructured":"Burns KH. Transposable elements in cancer. Nat Rev Cancer. 2017;17(7):415\u201324.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1618_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrm2858","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability - an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11(3):220\u20138.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1618_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","volume":"70","author":"M Kulis","year":"2010","unstructured":"Kulis M, Esteller M. DNA methylation and cancer. Adv Genet. 2010;70:27\u201356.","journal-title":"Adv Genet"},{"issue":"1","key":"1618_CR27","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s42003-021-01940-6","volume":"4","author":"M Zhang","year":"2021","unstructured":"Zhang M, et al. INPP4B protects from metabolic syndrome and associated disorders. Commun Biol. 2021;4(1):416.","journal-title":"Commun Biol"},{"issue":"17","key":"1618_CR28","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1007\/s00018-019-03359-z","volume":"77","author":"J Niska-Blakie","year":"2020","unstructured":"Niska-Blakie J, et al. Knockout of the non-essential gene SUGCT creates diet-linked, age-related microbiome disbalance with a diabetes-like metabolic syndrome phenotype. Cell Mol Life Sci. 2020;77(17):3423\u201339.","journal-title":"Cell Mol Life Sci"},{"issue":"24","key":"1618_CR29","doi-asserted-by":"publisher","first-page":"8386","DOI":"10.1158\/1078-0432.CCR-04-1029","volume":"10","author":"SA Ha","year":"2004","unstructured":"Ha SA, et al. Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis. Clin Cancer Res. 2004;10(24):8386\u201395.","journal-title":"Clin Cancer Res"},{"key":"1618_CR30","doi-asserted-by":"crossref","unstructured":"Sun, Y., et al., Loss of tumor suppressor inositol polyphosphate 4-phosphatase type B impairs DNA double-strand break repair by destabilization of DNA tethering protein Rad50. Cell Death & Disease, 2020. 11(4).","DOI":"10.1038\/s41419-020-2491-3"},{"key":"1618_CR31","doi-asserted-by":"crossref","unstructured":"Lambrechts, D., et al., Phenotype molding of stromal cells in the lung tumor microenvironment. Nature Medicine, 2018. 24(8): p. 1277-+.","DOI":"10.1038\/s41591-018-0096-5"},{"key":"1618_CR32","doi-asserted-by":"crossref","unstructured":"Kim, N., et al., Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nature Communications, 2020. 11(1).","DOI":"10.1038\/s41467-020-16164-1"},{"key":"1618_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semcancer.2016.02.001","volume":"40\u201341","author":"NS Yarla","year":"2016","unstructured":"Yarla NS, et al. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. Semin Cancer Biol. 2016;40\u201341:48\u201381.","journal-title":"Semin Cancer Biol"},{"key":"1618_CR34","doi-asserted-by":"crossref","unstructured":"Clemente, S.M., et al., Targeting Lipid Peroxidation for Cancer Treatment. Molecules, 2020. 25(21).","DOI":"10.3390\/molecules25215144"},{"issue":"39","key":"1618_CR35","doi-asserted-by":"publisher","first-page":"33832","DOI":"10.1074\/jbc.M110.216564","volume":"286","author":"YD Guo","year":"2011","unstructured":"Guo YD, et al. Identification of the Orphan G Protein-coupled Receptor GPR31 as a Receptor for 12-(S)-Hydroxyeicosatetraenoic Acid. J Biol Chem. 2011;286(39):33832\u201340.","journal-title":"J Biol Chem"},{"issue":"11","key":"1618_CR36","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.tips.2017.08.001","volume":"38","author":"BE Tourdot","year":"2017","unstructured":"Tourdot BE, Holinstat M. Targeting 12-Lipoxygenase as a Potential Novel Antiplatelet Therapy. Trends Pharmacol Sci. 2017;38(11):1006\u201315.","journal-title":"Trends Pharmacol Sci"},{"issue":"17","key":"1618_CR37","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1111\/bph.13210","volume":"172","author":"C Abrial","year":"2015","unstructured":"Abrial C, et al. 15-Lipoxygenases regulate the production of chemokines in human lung macrophages. Br J Pharmacol. 2015;172(17):4319\u201330.","journal-title":"Br J Pharmacol"},{"key":"1618_CR38","doi-asserted-by":"crossref","unstructured":"Younis, R.H., et al., Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile. Frontiers in Immunology, 2021. 12.","DOI":"10.3389\/fimmu.2021.596646"},{"issue":"18","key":"1618_CR39","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The Tumor Microenvironment Innately Modulates Cancer Progression. Can Res. 2019;79(18):4557\u201366.","journal-title":"Can Res"},{"issue":"10","key":"1618_CR40","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1002\/jcp.29601","volume":"235","author":"M Shahir","year":"2020","unstructured":"Shahir M, et al. Effect of mesenchymal stem cell-derived exosomes on the induction of mouse tolerogenic dendritic cells. J Cell Physiol. 2020;235(10):7043\u201355.","journal-title":"J Cell Physiol"},{"issue":"4","key":"1618_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ncb3124","volume":"17","author":"LK Boroughs","year":"2015","unstructured":"Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol. 2015;17(4):351\u20139.","journal-title":"Nat Cell Biol"},{"key":"1618_CR42","doi-asserted-by":"crossref","unstructured":"Vander Heiden, M.G. and R.J. DeBerardinis, Understanding the Intersections between Metabolism and Cancer Biology. Cell, 2017. 168(4).","DOI":"10.1016\/j.cell.2016.12.039"},{"issue":"2","key":"1618_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","volume":"73","author":"Z Li","year":"2016","unstructured":"Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2016;73(2):377\u201392.","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"1618_CR44","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1172\/JCI127201","volume":"129","author":"YH Cao","year":"2019","unstructured":"Cao YH. Adipocyte and lipid metabolism in cancer drug resistance. J Clin Investig. 2019;129(8):3006\u201317.","journal-title":"J Clin Investig"},{"issue":"1","key":"1618_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016;23(1):27\u201347.","journal-title":"Cell Metab"},{"key":"1618_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ymben.2016.10.022","volume":"43","author":"A Nilsson","year":"2017","unstructured":"Nilsson A, Nielsen J. Genome scale metabolic modeling of cancer. Metab Eng. 2017;43:103\u201312.","journal-title":"Metab Eng"},{"issue":"10","key":"1618_CR47","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.4161\/15592294.2014.969617","volume":"9","author":"GM Martin-Nunez","year":"2014","unstructured":"Martin-Nunez GM, et al. Type 2 diabetes mellitus in relation to global LINE-1 DNA methylation in peripheral blood: A cohort study. Epigenetics. 2014;9(10):1322\u20138.","journal-title":"Epigenetics"},{"issue":"11","key":"1618_CR48","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1007\/s11427-019-1563-3","volume":"62","author":"LG Chen","year":"2019","unstructured":"Chen LG, et al. Regulation of glucose and lipid metabolism in health and disease. Science China-Life Sciences. 2019;62(11):1420\u201358.","journal-title":"Science China-Life Sciences"},{"issue":"7","key":"1618_CR49","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41580-019-0123-5","volume":"20","author":"JJ Zhu","year":"2019","unstructured":"Zhu JJ, Thompson CB. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol. 2019;20(7):436\u201350.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1618_CR50","doi-asserted-by":"crossref","unstructured":"Cheng, C.M., et al., Lipid metabolism reprogramming and its potential targets in cancer. Cancer Communications, 2018. 38.","DOI":"10.1186\/s40880-018-0301-4"},{"issue":"9","key":"1618_CR51","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11306-018-1417-x","volume":"14","author":"SL Lim","year":"2018","unstructured":"Lim SL, et al. Metabolic signatures of four major histological types of lung cancer cells. Metabolomics. 2018;14(9):118.","journal-title":"Metabolomics"},{"issue":"7","key":"1618_CR52","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1158\/1940-6207.CAPR-14-0057","volume":"7","author":"FT Harris","year":"2014","unstructured":"Harris FT, et al. Acyl-coenzyme A-binding protein regulates Beta-oxidation required for growth and survival of non-small cell lung cancer. Cancer Prev Res (Phila). 2014;7(7):748\u201357.","journal-title":"Cancer Prev Res (Phila)"},{"key":"1618_CR53","doi-asserted-by":"crossref","unstructured":"Zhang, Y., et al., The FGGY Carbohydrate Kinase Family: Insights into the Evolution of Functional Specificities. Plos Computational Biology, 2011. 7(12).","DOI":"10.1371\/journal.pcbi.1002318"},{"issue":"5\u20136","key":"1618_CR54","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/17482960802673042","volume":"10","author":"MA Van Es","year":"2009","unstructured":"Van Es MA, et al. Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10(5\u20136):441-U274.","journal-title":"Amyotroph Lateral Scler"},{"issue":"2","key":"1618_CR55","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/en.2017-00711","volume":"159","author":"JA Taylor","year":"2018","unstructured":"Taylor JA, et al. Prenatal Exposure to Bisphenol A Disrupts Naturally Occurring Bimodal DNA Methylation at Proximal Promoter of fggy, an Obesity-Relevant Gene Encoding a Carbohydrate Kinase, in Gonadal White Adipose Tissues of CD-1 Mice. Endocrinology. 2018;159(2):779\u201394.","journal-title":"Endocrinology"},{"key":"1618_CR56","doi-asserted-by":"crossref","unstructured":"Sonnweber, T., et al., Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases. International Journal of Molecular Sciences, 2018. 19(11).","DOI":"10.3390\/ijms19113285"},{"issue":"7","key":"1618_CR57","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1194\/jlr.R068072","volume":"57","author":"SA Martin","year":"2016","unstructured":"Martin SA, Brash AR, Murphy RC. The discovery and early structural studies of arachidonic acid. J Lipid Res. 2016;57(7):1126\u201332.","journal-title":"J Lipid Res"},{"key":"1618_CR58","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.plipres.2018.11.001","volume":"73","author":"NK Singh","year":"2019","unstructured":"Singh NK, Rao GN. Emerging role of 12\/15-Lipoxygenase (ALOX15) in human pathologies. Prog Lipid Res. 2019;73:28\u201345.","journal-title":"Prog Lipid Res"},{"key":"1618_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.618501","volume":"12","author":"M Xu","year":"2021","unstructured":"Xu M, et al. Arachidonic Acid Metabolism Controls Macrophage Alternative Activation Through Regulating Oxidative Phosphorylation in PPARgamma Dependent Manner. Front Immunol. 2021;12: 618501.","journal-title":"Front Immunol"},{"key":"1618_CR60","doi-asserted-by":"crossref","unstructured":"Yang, F.J., et al., Ischemia reperfusion injury promotes recurrence of hepatocellular carcinoma in fatty liver via ALOX12\u201312HETE-GPR31 signaling axis. Journal of Experimental & Clinical Cancer Research, 2019. 38(1).","DOI":"10.1186\/s13046-019-1480-9"},{"issue":"1","key":"1618_CR61","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1167\/iovs.07-0855","volume":"49","author":"JG Lee","year":"2008","unstructured":"Lee JG, Kay EP. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells. Invest Ophthalmol Vis Sci. 2008;49(1):189\u201396.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1618_CR62","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1124\/mol.105.015818","volume":"69","author":"T Milojevic","year":"2006","unstructured":"Milojevic T, et al. The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor. Mol Pharmacol. 2006;69(4):1083\u201394.","journal-title":"Mol Pharmacol"},{"issue":"4","key":"1618_CR63","first-page":"340","volume":"1851","author":"WS Powell","year":"2015","unstructured":"Powell WS, Rokach J. Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid. BBA-Mol Cell Biol L. 2015;1851(4):340\u201355.","journal-title":"BBA-Mol Cell Biol L"},{"key":"1618_CR64","doi-asserted-by":"crossref","unstructured":"Zhang, X.J., et al., An ALOX12\u201312-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury. Nature Medicine, 2018. 24(1): p. 73-+.","DOI":"10.1038\/nm.4451"},{"issue":"9","key":"1618_CR65","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.4049\/jimmunol.0803874","volume":"182","author":"YP Cai","year":"2009","unstructured":"Cai YP, et al. Ym1\/2 Promotes Th2 Cytokine Expression by Inhibiting 12\/15(S)-Lipoxygenase: Identification of a Novel Pathway for Regulating Allergic Inflammation. J Immunol. 2009;182(9):5393\u20139.","journal-title":"J Immunol"},{"issue":"4","key":"1618_CR66","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1667\/RR15356.1","volume":"192","author":"EJ Chung","year":"2019","unstructured":"Chung EJ, et al. 12-Lipoxygenase is a Critical Mediator of Type II Pneumocyte Senescence, Macrophage Polarization and Pulmonary Fibrosis after Irradiation. Radiat Res. 2019;192(4):367\u201379.","journal-title":"Radiat Res"},{"key":"1618_CR67","doi-asserted-by":"crossref","unstructured":"Tarailo-Graovac, M. and N. Chen, Using RepeatMasker to identify repetitive elements in genomic sequences. Curr Protoc Bioinformatics, 2009. Chapter 4: p. Unit 4 10.","DOI":"10.1002\/0471250953.bi0410s25"},{"issue":"1","key":"1618_CR68","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/nar\/29.1.137","volume":"29","author":"KD Pruitt","year":"2001","unstructured":"Pruitt KD, Maglott DR. RefSeq and LocusLink: NCBI gene-centered resources. Nucleic Acids Res. 2001;29(1):137\u201340.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1618_CR69","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26(6):841\u20132.","journal-title":"Bioinformatics"},{"issue":"3","key":"1618_CR70","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul SF, et al. Basic local alignment search tool. J Mol Biol. 1990;215(3):403\u201310.","journal-title":"J Mol Biol"},{"issue":"14","key":"1618_CR71","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"issue":"16","key":"1618_CR72","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"issue":"23","key":"1618_CR73","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1093\/bioinformatics\/bts565","volume":"28","author":"L Fu","year":"2012","unstructured":"Fu L, et al. CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics. 2012;28(23):3150\u20132.","journal-title":"Bioinformatics"},{"issue":"1","key":"1618_CR74","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"2","key":"1618_CR75","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, et al. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15(2):R29.","journal-title":"Genome Biol"},{"key":"1618_CR76","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/1471-2105-11-587","volume":"11","author":"P Du","year":"2010","unstructured":"Du P, et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics. 2010;11:587.","journal-title":"BMC Bioinformatics"},{"issue":"43","key":"1618_CR77","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1618_CR78","doi-asserted-by":"crossref","unstructured":"Stuart T, et al. Comprehensive Integration of Single-Cell Data. Cell.\u00a02019;177(7):1888\u20131902 e21.","DOI":"10.1016\/j.cell.2019.05.031"},{"issue":"1","key":"1618_CR79","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim N, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285.","journal-title":"Nat Commun"},{"key":"1618_CR80","unstructured":"Subramanian, A., et al., A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. Cell, 2017. 171(6): p. 1437\u20131452 e17."},{"issue":"6","key":"1618_CR81","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3892\/or.2020.7810","volume":"44","author":"C Chen","year":"2020","unstructured":"Chen C, et al. Transcriptome sequencing analysis reveals unique and shared antitumor effects of three statins in pancreatic cancer. Oncol Rep. 2020;44(6):2569\u201380.","journal-title":"Oncol Rep"},{"issue":"11","key":"1618_CR82","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1158\/0008-5472.CAN-19-2852","volume":"80","author":"J Xie","year":"2020","unstructured":"Xie J, et al. GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate. Cancer Res. 2020;80(11):2150\u201362.","journal-title":"Cancer Res"},{"issue":"2","key":"1618_CR83","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166\u20139.","journal-title":"Bioinformatics"},{"key":"1618_CR84","doi-asserted-by":"crossref","unstructured":"Law, C.W., et al., voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biology, 2014. 15(2).","DOI":"10.1186\/gb-2014-15-2-r29"},{"issue":"5","key":"1618_CR85","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"GC Yu","year":"2012","unstructured":"Yu GC, et al. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. Omics-a Journal of Integrative Biology. 2012;16(5):284\u20137.","journal-title":"Omics-a Journal of Integrative Biology"},{"key":"1618_CR86","doi-asserted-by":"crossref","unstructured":"Yang G, et al. Histone acetyltransferase 1 is a succinyltransferase for histones and non-histones and promotes tumorigenesis. Embo Rep.\u00a02021;22(2).","DOI":"10.15252\/embr.202050967"},{"issue":"7","key":"1618_CR87","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/s41591-019-0520-5","volume":"25","author":"L Voorwerk","year":"2019","unstructured":"Voorwerk L, et al. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial (vol 25, pg 920, 2019). Nat Med. 2019;25(7):1175\u20131175.","journal-title":"Nat Med"},{"key":"1618_CR88","doi-asserted-by":"crossref","unstructured":"Hanker AB, et al. Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2\/HER3 activation, breast cancer progression, and HER2 inhibitor sensitivity. Cancer Res.\u00a02020;80(4).","DOI":"10.2139\/ssrn.3696760"},{"key":"1618_CR89","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.canlet.2019.11.001","volume":"469","author":"YN Ye","year":"2020","unstructured":"Ye YN, et al. Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b\/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma. Cancer Lett. 2020;469:310\u201322.","journal-title":"Cancer Lett"},{"issue":"6","key":"1618_CR90","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/j.ymthe.2021.02.016","volume":"29","author":"JY Ning","year":"2021","unstructured":"Ning JY, et al. Imbalance of TGF-beta 1\/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness. Mol Ther. 2021;29(6):2067\u201387.","journal-title":"Mol Ther"},{"issue":"1","key":"1618_CR91","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12943-020-01269-4","volume":"19","author":"S Shen","year":"2020","unstructured":"Shen S, et al. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc. Mol Cancer. 2020;19(1):151.","journal-title":"Mol Cancer"},{"issue":"4","key":"1618_CR92","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1093\/nar\/gky1241","volume":"47","author":"Z Jia","year":"2019","unstructured":"Jia Z, et al. A coronary artery disease-associated tRNAThr mutation altered mitochondrial function, apoptosis and angiogenesis. Nucleic Acids Res. 2019;47(4):2056\u201374.","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-022-01618-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-022-01618-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-022-01618-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T10:22:10Z","timestamp":1657966930000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-022-01618-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,16]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1618"],"URL":"https:\/\/doi.org\/10.1186\/s12943-022-01618-5","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,16]]},"assertion":[{"value":"1 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was approved by the Ethics Committee of Tianjin Medical University (Approved No.: Ek2020111) and written informed consents were obtained from the patients. All experiments were performed in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"W.Z. reports personal fees from VericiDx and the following patents: (i) Patents US provisional patent application F&R ref 27527-0134P01, serial no. 61\/951,651, filled March 2014: Method for identifying kidney allograft recipients at risk for chronic injury; (ii) US provisional patent application: Methods for diagnosing risk of renal allograft fibrosis and rejection (miRNA); (iii) US provisional patent application: Method for diagnosing subclinical acute rejection by RNA sequencing analysis of a predictive gene set; and (iv) US provisional patent application: Pretransplant prediction of posttransplant acute rejection. PJO\u2019C is a consultant for CSL Behring and Vitaeris. All the other authors declared no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}